Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$3.2 million.

  • Maravai Lifesciences Holdings' Other Non Operating Income fell 198.61% to -$71,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 110.36%. This contributed to the annual value of -$3.2 million for FY2024, which is 138.37% down from last year.
  • As of FY2024, Maravai Lifesciences Holdings' Other Non Operating Income stood at -$3.2 million, which was down 138.37% from -$1.3 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Non Operating Income registered a high of $279,000 during FY2021, and its lowest value of -$7.6 million during FY2020.
  • Its 3-year average for Other Non Operating Income is -$1.6 million, with a median of -$1.3 million in 2023.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Other Non Operating Income crashed by 6,533.90% in 2020, and later skyrocketed by 103.67% in 2021.
  • Maravai Lifesciences Holdings' Other Non Operating Income (Yearly) stood at -$7.6 million in 2020, then skyrocketed by 103.67% to $279,000 in 2021, then slumped by 228.32% to -$358,000 in 2022, then plummeted by 273.46% to -$1.3 million in 2023, then tumbled by 138.37% to -$3.2 million in 2024.